7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 
      
    		                                         
      cash flows from operating activities
    		                                         
      net income
    		60,000,000 -380,000,000 -4,000,000 -8,000,000 -27,000,000 69,000,000 52,000,000 -25,000,000 19,000,000 -376,000,000 145,000,000 -97,000,000 241,000,000 200,000,000 234,000,000 233,000,000 214,000,000 65,000,000 96,000,000 19,000,000 76,000,000 24,000,000 100,000,000 -317,000,000 76,000,000 95,000,000 94,000,000 142,000,000 275,000,000 282,000,000 297,000,000 228,000,000 207,000,000 161,000,000 151,000,000 -230,000,000 204,000,000 -18,000,000 51,000,000 -86,000,000 -29,000,000 
      adjustments to reconcile net income to cash from operating activities:
    		                                         
      depreciation and amortization
    		79,000,000 92,000,000 88,000,000 78,000,000 78,000,000 74,000,000 71,000,000 74,000,000 76,000,000 78,000,000 79,000,000 74,000,000 71,000,000 72,000,000 74,000,000 75,000,000 79,000,000 80,000,000 83,000,000 80,000,000 80,000,000 81,000,000 79,000,000 79,000,000 78,000,000 78,000,000 76,000,000 71,000,000 71,000,000 72,000,000 70,000,000 69,000,000 62,000,000 71,000,000 71,000,000 72,000,000 73,000,000 73,000,000 66,000,000 66,000,000 70,000,000 
      gain on sales of assets and businesses
    		-7,000,000 0 -1,000,000 0 0 0 -3,000,000 -4,000,000    6,000,000 0   -113,000,000 0       1,000,000 -8,000,000   0              
      equity in earnings of affiliates
    		-7,000,000 -9,000,000 -7,000,000 30,000,000 -11,000,000 -9,000,000 -11,000,000 43,000,000 -11,000,000 -12,000,000 -9,000,000 14,000,000 -13,000,000 -14,000,000 -9,000,000 20,000,000 -12,000,000 -9,000,000 -10,000,000  -5,000,000 -7,000,000 -4,000,000 21,000,000 -9,000,000 -8,000,000 -7,000,000 22,000,000 -10,000,000 -11,000,000 17,000,000 -7,000,000 -9,000,000 -10,000,000 -7,000,000  -8,000,000 -4,000,000 -5,000,000   
      amortization of debt issuance costs and issue discounts
    		3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 2,000,000 2,000,000 2,000,000 2,000,000 3,000,000 2,000,000 2,000,000 3,000,000 2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 3,000,000 2,000,000 2,000,000 2,000,000 2,000,000 3,000,000 2,000,000 2,000,000             
      deferred tax provision
    		-16,000,000          1,000,000 14,000,000   19,000,000             20,000,000 -35,000,000 3,000,000 35,000,000 30,000,000 15,000,000         
      asset-related charges
    		16,000,000 10,000,000 1,000,000 2,000,000    -28,000,000 112,000,000 0 11,000,000 0 0 0 5,000,000     6,000,000 5,000,000 10,000,000 1,000,000 31,000,000        0 1,000,000         
      stock-based compensation expense
    		5,000,000 7,000,000 5,000,000 3,000,000 5,000,000 6,000,000 1,000,000 5,000,000 6,000,000 3,000,000 4,000,000 3,000,000 7,000,000 7,000,000 10,000,000 10,000,000 4,000,000 8,000,000 12,000,000 4,000,000 3,000,000 1,000,000 8,000,000 1,000,000 4,000,000 6,000,000 8,000,000               
      net periodic pension (income) cost
    		                                         
      defined benefit plan contributions
    		6,000,000 -4,000,000 -4,000,000 -3,000,000 -2,000,000 -3,000,000 -4,000,000 -1,000,000 -2,000,000 -2,000,000 -5,000,000 -1,000,000 -2,000,000 -2,000,000 -5,000,000 -5,000,000 -4,000,000 -3,000,000 -5,000,000 -4,000,000 -3,000,000 -6,000,000 -8,000,000 -4,000,000 -2,000,000 -7,000,000 -6,000,000               
      other operating charges and credits
    		5,000,000 -23,000,000 37,000,000 -33,000,000 9,000,000 -7,000,000 -11,000,000 15,000,000 -9,000,000 -1,000,000 -4,000,000 3,000,000 -16,000,000 -14,000,000 6,000,000 -3,000,000 -3,000,000 -5,000,000 29,000,000 -11,000,000 -8,000,000 -6,000,000 3,000,000 0 -3,000,000 -3,000,000 4,000,000 8,000,000 -1,000,000 2,000,000 8,000,000 15,000,000 13,000,000 3,000,000 10,000,000 19,000,000    -15,000,000 -5,000,000 
      goodwill impairment
    		   0                                      
      decrease (increase) in operating assets:
    		                                         
      accounts and notes receivable
    		11,000,000 -63,000,000 -111,000,000 196,000,000 -59,000,000 -112,000,000 -177,000,000 202,000,000 49,000,000 -56,000,000 -205,000,000 347,000,000 83,000,000 -45,000,000 -294,000,000 118,000,000 -55,000,000 -75,000,000 -213,000,000 78,000,000 -31,000,000 139,000,000 -11,000,000 159,000,000 48,000,000 -32,000,000 16,000,000 134,000,000 88,000,000 -25,000,000 -150,000,000           
      inventories and other current operating assets
    		-34,000,000 9,000,000 -51,000,000 -55,000,000 -76,000,000 19,000,000 -34,000,000                                   
      other non-current operating assets
    		6,000,000 16,000,000 48,000,000 -146,000,000 -4,000,000 21,000,000 31,000,000                                   
      increase in operating liabilities:
    		                                         
      accounts payable
    		8,000,000 18,000,000 -105,000,000 86,000,000 83,000,000 -21,000,000 -157,000,000                                   
      other current operating liabilities
    		9,000,000 88,000,000 -5,000,000 -36,000,000 66,000,000 -644,000,000 -46,000,000                                   
      other non-current operating liabilities
    		3,000,000 230,000,000 9,000,000  15,000,000 -6,000,000 -5,000,000                                   
      cash from operating activities
    		146,000,000 93,000,000 -112,000,000 138,000,000 139,000,000 -620,000,000 -290,000,000 484,000,000 130,000,000 61,000,000 -119,000,000 160,000,000 301,000,000 291,000,000 2,000,000 214,000,000 311,000,000 256,000,000 39,000,000 353,000,000 299,000,000 111,000,000 44,000,000 400,000,000 288,000,000 6,000,000 -44,000,000 259,000,000 342,000,000 343,000,000 196,000,000 303,000,000 112,000,000 183,000,000 41,000,000 270,000,000 198,000,000 90,000,000 36,000,000 302,000,000 113,000,000 
      capex
    		-39,000,000 -43,000,000 -58,000,000 -113,000,000 -28,000,000 -73,000,000 -58,000,000 -129,000,000 -63,000,000 -39,000,000 -57,000,000 -30,000,000 -71,000,000 -58,000,000 -69,000,000 -38,000,000 -66,000,000 -68,000,000 -16,000,000 -53,000,000 -47,000,000 -61,000,000 -106,000,000 -96,000,000 -128,000,000 -124,000,000 -133,000,000 -154,000,000 -116,000,000 -126,000,000 -102,000,000 0 -108,000,000 -69,000,000 -69,000,000 -103,000,000 -67,000,000 -79,000,000 -89,000,000 -127,000,000 -105,000,000 
      free cash flows
    		107,000,000 50,000,000 -170,000,000 25,000,000 111,000,000 -693,000,000 -348,000,000 355,000,000 67,000,000 22,000,000 -176,000,000 130,000,000 230,000,000 233,000,000 -67,000,000 176,000,000 245,000,000 188,000,000 23,000,000 300,000,000 252,000,000 50,000,000 -62,000,000 304,000,000 160,000,000 -118,000,000 -177,000,000 105,000,000 226,000,000 217,000,000 94,000,000 303,000,000 4,000,000 114,000,000 -28,000,000 167,000,000 131,000,000 11,000,000 -53,000,000 175,000,000 8,000,000 
      cash flows from investing activities
    		                                         
      purchases of property, plant, and equipment
    		-41,000,000 -43,000,000 -84,000,000 -109,000,000 -76,000,000 -73,000,000 -102,000,000 -135,000,000 -86,000,000 -58,000,000 -91,000,000 -67,000,000 -72,000,000 -62,000,000 -106,000,000 -83,000,000 -67,000,000 -67,000,000 -60,000,000 -53,000,000 -47,000,000 -61,000,000 -106,000,000 -96,000,000 -128,000,000 -124,000,000 -133,000,000 -154,000,000 -116,000,000 -126,000,000 -102,000,000           
      proceeds from sales of assets and businesses
    		6,000,000    0 0 3,000,000      0 32,000,000 1,000,000         2,000,000 6,000,000   0   39,000,000 0 1,000,000         
      foreign exchange contract settlements
    		-1,000,000 0 -2,000,000   1,000,000 -2,000,000 0 0 -2,000,000 -6,000,000 2,000,000 2,000,000 4,000,000 -5,000,000 -3,000,000 -2,000,000 10,000,000 -17,000,000 13,000,000 10,000,000 10,000,000 -6,000,000    -1,000,000 -6,000,000 14,000,000 -11,000,000 5,000,000 -3,000,000 3,000,000 5,000,000 -3,000,000 -11,000,000   -1,000,000 -19,000,000 73,000,000 
      other investing activities
    		   0 0   0    0 -4,000,000                             
      cash from investing activities
    		-35,000,000 -42,000,000 -86,000,000 -107,000,000 -75,000,000 -70,000,000 -101,000,000 -130,000,000 58,000,000 -60,000,000 -97,000,000 -65,000,000 -74,000,000 -35,000,000 -110,000,000 422,000,000 -68,000,000 -57,000,000 -77,000,000 -24,000,000 -47,000,000 -51,000,000 -112,000,000 -96,000,000 -131,000,000 -122,000,000 -134,000,000 -160,000,000 -97,000,000 -172,000,000 -58,000,000 -168,000,000 -104,000,000 -35,000,000 -63,000,000 -112,000,000 487,000,000 -68,000,000 50,000,000 -142,000,000 -32,000,000 
      cash flows from financing activities
    		                                         
      proceeds from issuance of debt
    		0       0        0            0 0   1,000,000 0       1,000,000 0 
      debt repayments
    		-8,000,000 -103,000,000 -8,000,000 -477,000,000 -8,000,000 -2,000,000 -3,000,000 -3,000,000 -271,000,000 -3,000,000 -3,000,000 -4,000,000 -57,000,000 -3,000,000 -4,000,000 -70,000,000 -757,000,000 -24,000,000 -3,000,000 -803,000,000 -6,000,000 -6,000,000 -128,000,000 -22,000,000 -9,000,000 -3,000,000 -3,000,000 -4,000,000 -3,000,000 -668,000,000 -4,000,000 -3,000,000 -4,000,000 -16,000,000 -4,000,000 -169,000,000 -117,000,000 -86,000,000 -9,000,000 -4,000,000  
      payments of debt issuance cost
    		0            0                             
      payments on finance leases
    		-5,000,000 -4,000,000 -3,000,000 -3,000,000 -3,000,000 -3,000,000 -3,000,000 -3,000,000 -2,000,000 -3,000,000 -3,000,000 -2,000,000 -3,000,000 -3,000,000 -3,000,000 -2,000,000 -3,000,000 -3,000,000 -2,000,000 -2,000,000 -1,000,000 -2,000,000 -1,000,000 -1,000,000                  
      proceeds from supplier financing program
    		17,000,000 20,000,000 27,000,000  20,000,000 20,000,000 27,000,000                                   
      payments to supplier financing program
    		-17,000,000 -18,000,000 -35,000,000 -22,000,000 -19,000,000 -24,000,000 -37,000,000                                   
      proceeds from exercised stock options
    		   1,000,000 0 7,000,000 1,000,000 1,000,000 9,000,000 7,000,000 2,000,000 0 3,000,000 42,000,000 6,000,000 8,000,000 4,000,000 5,000,000 6,000,000 7,000,000 4,000,000 0 5,000,000 1,000,000 0 2,000,000 6,000,000 1,000,000 2,000,000 8,000,000 5,000,000 1,000,000 4,000,000 6,000,000 20,000,000       
      payments related to tax withholdings on vested stock awards
    		0 0 -1,000,000  0 -1,000,000 -2,000,000  0 0 -18,000,000  0 0 -4,000,000 0 0 0 -2,000,000 0 0 0 -2,000,000 0 0 0 -30,000,000               
      payments of dividends to the company's common shareholders
    		-13,000,000 -13,000,000 -37,000,000 -36,000,000 -38,000,000 -37,000,000 -37,000,000 -37,000,000 -37,000,000 -38,000,000 -37,000,000 -37,000,000 -39,000,000 -38,000,000 -40,000,000 -41,000,000 -41,000,000 -41,000,000 -41,000,000 -41,000,000 -41,000,000                     
      other financing activities
    		   0                                      
      cash from financing activities
    		-5,000,000 -27,000,000 -57,000,000 85,000,000 -27,000,000 -40,000,000 -54,000,000 -7,000,000 325,000,000 -73,000,000 -73,000,000 -190,000,000 -175,000,000 -131,000,000 -189,000,000 -201,000,000 -241,000,000 -76,000,000 -42,000,000 -197,000,000 -344,000,000 247,000,000 -155,000,000 -59,000,000 -77,000,000 41,000,000 -324,000,000 -170,000,000 -182,000,000 -370,000,000 -271,000,000 -115,000,000 -15,000,000 472,000,000 11,000,000 -166,000,000 -122,000,000 -92,000,000 -16,000,000 -8,000,000 -108,000,000 
      effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents
    		6,000,000 15,000,000 6,000,000 -19,000,000 10,000,000 -4,000,000 -9,000,000 13,000,000 -11,000,000 -4,000,000 6,000,000 31,000,000 -32,000,000 -22,000,000 -9,000,000 -15,000,000                          
      decrease in cash, cash equivalents, restricted cash and restricted cash equivalents
    		112,000,000 39,000,000 -249,000,000   -734,000,000 -454,000,000   -76,000,000 -283,000,000    -306,000,000                           
      cash, cash equivalents, restricted cash and restricted cash equivalents at january 1,
    		0 0 763,000,000  0 0 1,807,000,000  0 0 1,304,000,000                               
      cash, cash equivalents, restricted cash and restricted cash equivalents at september 30,
    		                                         
      supplemental cash flows information
    		                                         
      non-cash investing and financing activities:
    		                                         
      purchases of property, plant, and equipment included in accounts payable
    		2,000,000 0 26,000,000 -4,000,000 48,000,000 0 44,000,000 6,000,000 23,000,000 19,000,000 34,000,000 37,000,000 1,000,000 4,000,000 37,000,000 45,000,000 1,000,000 -1,000,000 44,000,000                       
      net periodic pension cost
    		   4,000,000 0 1,000,000 1,000,000 1,000,000 4,000,000 2,000,000 2,000,000 3,000,000 2,000,000 1,000,000 3,000,000 1,000,000 2,000,000 2,000,000 1,000,000 5,000,000 3,000,000 3,000,000 3,000,000 377,000,000 3,000,000 0 1,000,000               
      cash, cash equivalents, restricted cash and restricted cash equivalents at june 30,
    		                                         
      deferred tax benefit
    		  -15,000,000 7,000,000 -22,000,000 -11,000,000 -1,000,000 -23,000,000 -64,000,000       -22,000,000 -16,000,000 -33,000,000 -6,000,000 -15,000,000 -35,000,000 -27,000,000 -43,000,000 -148,000,000   -7,000,000             -112,000,000 -55,000,000 
      cash, cash equivalents, restricted cash and restricted cash equivalents at march 31,
    		  514,000,000    1,353,000,000    1,021,000,000    1,245,000,000                           
      gain on extinguishment of debt
    		       0                                  
      non-current operating liabilities
    		                                         
      proceeds from sales of assets and businesses, net of cash divested
    		                                         
      payments of debt issuance costs
    		                           0 0             
      proceeds from supplier financing programs
    		                                         
      purchases of treasury stock, at cost
    		       0 -18,000,000 -37,000,000 -14,000,000 -144,000,000 -79,000,000 -128,000,000 -144,000,000 -93,000,000 -67,000,000       0 0 -67,000,000 -255,000,000 -124,000,000 -126,000,000             
      payments related to tax withheld on vested stock awards
    		                                         
      (distributions to) cash received from non-controlling interest shareholders
    		                                         
      increase in cash, cash equivalents, restricted cash and restricted cash equivalents
    		   97,000,000    360,000,000    -64,000,000 20,000,000   420,000,000                          
      cash, cash equivalents, restricted cash, and restricted cash equivalents at january 1,
    		           0 0 0 1,551,000,000 0                          
      cash, cash equivalents, restricted cash, and restricted cash equivalents at december 31,
    		                                         
      cash paid during the year for:
    		                                         
      interest, net of amounts capitalized
    		                                         
      income taxes, net of refunds
    		                                         
      treasury stock repurchased, not settled
    		           -9,000,000 8,000,000 -4,000,000 6,000,000 2,000,000 0                         
      loss on extinguishment of debt
    		               1,000,000             0             
      cash received from non-controlling interest shareholder
    		        0                                 
      payments related to extinguishment of debt
    		               0            0 0             
      cash received (distributions to) non-controlling interest shareholders
    		                                         
      inventories and other operating assets
    		        69,000,000 58,000,000 -32,000,000 -131,000,000 -173,000,000 -77,000,000 -9,000,000 -124,000,000 -18,000,000 -29,000,000 -31,000,000 15,000,000 78,000,000 75,000,000 -42,000,000 162,000,000 24,000,000 -21,000,000 -49,000,000 -111,000,000 -90,000,000 -67,000,000 -29,000,000 -117,000,000 -48,000,000 -12,000,000 -31,000,000 34,000,000 28,000,000 67,000,000 18,000,000 48,000,000 39,000,000 
      accounts payable and other operating liabilities
    		        -16,000,000 437,000,000 -108,000,000 -77,000,000 90,000,000 216,000,000 -34,000,000 20,000,000 98,000,000 255,000,000 81,000,000 144,000,000 134,000,000 -179,000,000 -44,000,000 36,000,000 82,000,000 -110,000,000 -177,000,000 -33,000,000 42,000,000 48,000,000 -13,000,000 68,000,000 -192,000,000 -4,000,000 -42,000,000 360,000,000 -34,000,000 44,000,000 -38,000,000 165,000,000 -46,000,000 
      (gain) loss on extinguishment of debt
    		           0                              
      proceeds from accounts receivable securitization facility
    		                   0 0 0 12,000,000 3,000,000                  
      repayments on accounts receivable securitization facility
    		                                         
      proceeds from revolving loan
    		                   0 0   0 0                 
      repayments on revolving loan
    		                   0    0                  
      deferred acquisition-related consideration
    		                                         
      distributions to non-controlling interest shareholders
    		               0    0 0                     
      non-cash financing arrangements
    		                   1,000,000    0                  
      acquisition of business
    		                       0    0 0             
      proceeds from life insurance policies
    		               0        0                  
      obligations incurred under build-to-suit lease arrangement
    		                       5,000,000 5,000,000 13,000,000 17,000,000 6,000,000 15,000,000 15,000,000 11,000,000           
      deferred payments related to acquisition of business
    		                       0                  
      effect of exchange rate changes on cash and cash equivalents
    		                 8,000,000 -17,000,000 17,000,000 17,000,000 10,000,000 -6,000,000 4,000,000 -16,000,000 8,000,000 -2,000,000 -3,000,000 -5,000,000 -18,000,000 11,000,000 1,000,000 13,000,000         
      increase in cash and cash equivalents
    		                   149,000,000 -75,000,000       -74,000,000 58,000,000   21,000,000 6,000,000 631,000,000 -4,000,000 -55,000,000      
      cash and cash equivalents at january 1,
    		                 0 1,105,000,000 0 0 0 943,000,000 0 0 0 1,201,000,000 0 0 0 1,556,000,000           
      cash and cash equivalents at june 30,
    		                                         
      decrease in cash and cash equivalents
    		                  -97,000,000    -229,000,000  64,000,000 -67,000,000 -504,000,000    -122,000,000           
      cash and cash equivalents at march 31,
    		                  1,008,000,000    714,000,000    697,000,000    1,434,000,000           
      cash and cash equivalents at december 31,
    		                                         
      changes in property, plant, and equipment included in accounts payable
    		                   6,000,000 0 -12,000,000 37,000,000 17,000,000 93,000,000 -14,000,000 -11,000,000 25,000,000 13,000,000 0 -1,000,000           
      cash and cash equivalents at september 30,
    		                                         
      payments of dividends
    		                      -41,000,000 -40,000,000 -41,000,000 -41,000,000 -42,000,000 -42,000,000 -45,000,000             
      purchases of treasury stock not settled by period-end
    		                                         
      purchases of treasury stock not settled by year-end
    		                                         
      dividends accrued but not yet paid
    		                                         
      purchases of treasury stock not settled by quarter-end
    		                          6,000,000    15,000,000           
      tax payments accrued for withholdings on vested restricted stock units
    		                              4,000,000           
      investments in affiliates
    		                                         
      payments related to tax withholdings on vested restricted stock units
    		                           -1,000,000 -10,000,000             
      gain on sale of assets and businesses
    		                             -3,000,000 -42,000,000  0 2,000,000 -16,000,000       
      proceeds from sale of assets and businesses
    		                                         
      amortization of deferred financing costs and issuance discount
    		                              3,000,000 3,000,000 3,000,000 4,000,000 3,000,000       
      purchases of treasury stock at cost
    		                              -240,000,000           
      tax payments related to withholdings on vested restricted stock units
    		                              -1,000,000 -2,000,000          
      payment of dividends
    		                              -31,000,000           
      (gain) loss on sale of assets and businesses
    		                                         
      payment of deferred financing fees
    		                                         
      cash provided at separation by dupont
    		                                       0 0 
      net transfers to dupont
    		                                         
      operating activities
    		                                         
      increase in operating assets:
    		                                         
      accounts and notes receivable - trade
    		                                60,000,000 -67,000,000 -103,000,000 68,000,000 29,000,000 -52,000,000 -40,000,000 186,000,000 -45,000,000 
      investing activities
    		                                         
      purchases of property, plant and equipment
    		                                -108,000,000 -69,000,000 -69,000,000 -103,000,000 -67,000,000 -79,000,000 -89,000,000 -127,000,000 -105,000,000 
      investment in affiliates
    		                                   1,000,000    0 0 
      financing activities
    		                                         
      dividends paid
    		                                -5,000,000 -6,000,000 -5,000,000 -6,000,000 -5,000,000 -6,000,000 -5,000,000 -5,000,000  
      deferred financing fees
    		                                0    0 0 -2,000,000   
      cash and cash equivalents at beginning of the period
    		                                0 0 902,000,000       
      cash and cash equivalents at end of the period
    		                                6,000,000 631,000,000 898,000,000       
      non-cash investing activities
    		                                         
      change in property, plant and equipment included in accounts payable
    		                                -11,000,000 -19,000,000 14,000,000  -1,000,000 7,000,000 3,000,000  -7,000,000 
      deferred tax benefits
    		                                  5,000,000 -82,000,000 7,000,000     
      proceeds from sales of assets and business
    		                                  9,000,000   10,000,000 140,000,000   
      effect of exchange rate changes on cash
    		                                  7,000,000   18,000,000 -1,000,000 -1,000,000  
      non-cash investing activites:
    		                                         
      equity in earnings of affiliates, net of dividends received of 18, 23 and 19
    		                                         
      asset related charges
    		                                   15,000,000 46,000,000   15,000,000  
      proceeds from sales of assets
    		                                       4,000,000 0 
      debt issuance costs
    		                                       0 -2,000,000 
      net transfers (to) from dupont
    		                                       0 0 
      cash and cash equivalents at beginning of year
    		                                         
      cash and cash equivalents at end of year
    		                                         
      supplemental cash flow information:
    		                                         
      non-cash change in property, plant and equipment included in accounts payable
    		                                         
      amortization of debt issuance costs and discount
    		                                    4,000,000 3,000,000 8,000,000   
      gain on sale of assets and business
    		                                    -170,000,000 1,000,000 -89,000,000   
      decrease in operating liabilities:
    		                                         
      proceeds from sales of assets and business, net of cash transferred
    		                                         
      cash and cash equivalents at beginning of period
    		                                         
      cash and cash equivalents at end of period
    		                                         
      non-cash investing activities:
    		                                         
      other operating charges
    		                                     -41,000,000 55,000,000   
      increase in cash
    		                                     -52,000,000 69,000,000 151,000,000 -32,000,000 
      cash at beginning of period
    		                                     0 366,000,000   
      cash at end of period
    		                                     -52,000,000 435,000,000  -32,000,000 
      employee separation (credit) charges
    		                                         
      decommissioning and other charges
    		                                     -2,000,000 13,000,000   
      asset related charges - impairment 1
    		                                         
      total
    		                                     50,000,000 17,000,000   
      deferred tax expense
    		                                      10,000,000   
      net transfers from dupont
    		                                         
      employee separation charges
    		                                      4,000,000   
      equity in earnings of affiliates, net of dividends received of 23, 19 and 19
    		                                         
      cash at beginning of year
    		                                         
      cash at end of year
    		                                         
      selling segment
    		                                         
      titanium technologies
    		                                         
      fluoroproducts
    		                                         
      chemical solutions
    		                                         
      equity in earnings of affiliates, net of dividends received of 0 and 1
    		                                        -7,000,000 
      payments of long-term capital lease obligations
    		                                         
      supplemental disclosure of significant non-cash investing activities:
    		                                         
      net
    		                                         
      historical pro forma earnings per share data
    		                                         
      earnings per share attributable to chemours
    		                                         
      basic and diluted
    		                                         
      weighted-average number of shares outstanding
    		                                         
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.